An immune related cell death index for prognostic stratification and immunotherapy response prediction in oral cancer

{"Immune-related":[0],"cell":[1,21,64,73,80,117],"death":[2,22,74,81],"(IRCD)":[3],"plays":[4],"a":[5,110,135,145],"crucial":[6],"role":[7,138],"in":[8,62,139,149],"the":[9,51,60,140],"immune":[10,45,63,104],"microenvironment,":[11],"development,":[12],"and":[13,48,54,68,99,109,119,154],"deterioration":[14],"of":[15,112,175],"oral":[16,34,176],"cancer.":[17,177],"However,":[18],"reliable":[19],"immune-related":[20,72,79],"profiles":[23],"have":[24],"not":[25],"been":[26],"explored.":[27],"In":[28],"this":[29],"study,":[30],"based":[31,77],"on":[32,78],"multiple":[33,150],"cancer":[35],"datasets":[36],"such":[37],"as":[38,94],"TCGA,":[39],"tumors":[40],"were":[41,57],"divided":[42],"into":[43],"two":[44,61],"subtypes,":[46],"\\"Hot\\"":[47],"\\"Cold\\",":[49],"using":[50],"ConsensusClusterPlus":[52],"algorithm,":[53,142],"significant":[55],"differences":[56],"found":[58],"between":[59],"infiltration,":[65],"microenvironment":[66],"activity,":[67,105],"immunotherapy":[69,152],"responsiveness.":[70],"The":[71],"index":[75],"(IRCDI)":[76],"gene":[82,106],"(IRCDG)":[83],"was":[84,126],"further":[85],"constructed":[86],"to":[87,103,129,158,166,171],"reveal":[88],"that":[89,123,162],"IRCDI":[90,125,133,163],"can":[91],"be":[92,167],"used":[93],"an":[95,168],"independent":[96],"prognostic":[97],"indicator":[98],"is":[100,164],"closely":[101,127],"related":[102,128],"mutation":[107],"characteristics":[108],"variety":[111],"signaling":[113],"pathways.":[114],"Both":[115],"single":[116],"analysis":[118,121],"immunosubtype":[120],"showed":[122],"low":[124],"enhanced":[130],"immunocompetence.":[131],"Although":[132],"has":[134,144],"limited":[136],"predictive":[137,147],"TIDE":[141],"it":[143],"good":[146],"ability":[148],"real":[151],"cohorts":[153],"shows":[155],"specific":[156],"sensitivity":[157],"different":[159],"drugs,":[160],"suggesting":[161],"expected":[165],"important":[169],"biomarker":[170],"guide":[172],"individualized":[173],"treatment":[174]}